89bio, Inc. Financing Cash Flow
89bio, Inc. reported Financing Cash Flow of $289.63 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-08-08
- 89bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $20.73M, a 25.87% decline year-over-year.
- 89bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $268.91M, a 1178.68% increase year-over-year.
- 89bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $136.41M, a 15.89% decline year-over-year.
- 89bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $33.19M.
- 89bio, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $218.59M, a 57.40% decline from fiscal 2023.
- 89bio, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $513.11M, a 335.46% increase from fiscal 2022.
- 89bio, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $117.83M, a 393.62% increase from fiscal 2021.
- 89bio, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $23.87M, a 84.88% decline from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 8 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 11 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|
| 2025-06-30 | $20.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $289.63M 10-Q · filed 2025-08-08 | $426.04M derived: sum of 3 quarters · filed 2025-08-08 | $459.23M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2025-03-31 | $268.91M 10-Q · filed 2025-05-02 | $405.31M derived: sum of 2 quarters · filed 2025-05-02 | $438.50M derived: sum of 3 quarters · filed 2025-05-02 | $466.46M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-12-31 | $136.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $169.60M derived: sum of 2 quarters · filed 2025-02-27 | $197.56M derived: sum of 3 quarters · filed 2025-08-08 | $218.59M 10-K · filed 2025-02-27 | ||
| 2024-09-30 | $33.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $61.15M derived: sum of 2 quarters · filed 2025-08-08 | $82.18M 10-Q · filed 2024-11-07 | $244.35M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-06-30 | $27.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $48.99M 10-Q · filed 2025-08-08 | $211.16M derived: sum of 3 quarters · filed 2025-08-08 | $209.68M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | $21.03M 10-Q · filed 2025-05-02 | $183.20M derived: sum of 2 quarters · filed 2025-05-02 | $181.72M derived: sum of 3 quarters · filed 2025-05-02 | $212.49M derived: sum of 4 quarters · filed 2025-05-02 | ||
| 2023-12-31 | $162.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $160.69M derived: sum of 2 quarters · filed 2025-02-27 | $191.46M derived: sum of 3 quarters · filed 2025-02-27 | $513.11M 10-K · filed 2025-02-27 | ||
| 2023-09-30 | -$1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $29.29M derived: sum of 2 quarters · filed 2024-11-07 | $350.94M 10-Q · filed 2024-11-07 | $371.95M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $30.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $352.42M 10-Q · filed 2024-08-05 | $373.43M derived: sum of 3 quarters · filed 2025-02-27 | $442.06M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $321.65M 10-Q · filed 2024-05-09 | $342.67M derived: sum of 2 quarters · filed 2025-02-27 | $411.30M derived: sum of 3 quarters · filed 2025-02-27 | $439.46M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $21.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $89.64M derived: sum of 2 quarters · filed 2025-02-27 | $117.80M derived: sum of 3 quarters · filed 2025-02-27 | $117.83M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $68.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $96.79M derived: sum of 2 quarters · filed 2023-11-09 | $96.82M 10-Q · filed 2023-11-09 | $118.71M derived: sum of 4 quarters · filed 2024-03-01 | ||
| 2022-06-30 | $28.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $28.19M 10-Q · filed 2023-08-09 | $50.08M derived: sum of 3 quarters · filed 2024-03-01 | $50.15M derived: sum of 4 quarters · filed 2024-03-01 | ||
| 2022-03-31 | $29.00K 10-Q · filed 2023-05-08 | $21.92M derived: sum of 2 quarters · filed 2024-03-01 | $21.99M derived: sum of 3 quarters · filed 2024-03-01 | $23.68M derived: sum of 4 quarters · filed 2024-03-01 | ||
| 2021-12-31 | $21.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $21.96M derived: sum of 2 quarters · filed 2024-03-01 | $23.66M derived: sum of 3 quarters · filed 2024-03-01 | $23.87M 10-K · filed 2024-03-01 | ||
| 2021-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.76M derived: sum of 2 quarters · filed 2022-11-10 | $1.98M 10-Q · filed 2022-11-10 | $1.67M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.91M 10-Q · filed 2022-08-11 | $1.60M derived: sum of 3 quarters · filed 2022-08-11 | $159.89M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $216.00K 10-Q · filed 2022-05-12 | -$96.00K derived: sum of 2 quarters · filed 2022-05-12 | $158.20M derived: sum of 3 quarters · filed 2022-05-12 | $158.13M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $157.98M derived: sum of 2 quarters · filed 2022-03-24 | $157.91M derived: sum of 3 quarters · filed 2022-03-24 | $157.92M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $158.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $158.23M derived: sum of 2 quarters · filed 2021-11-12 | $158.24M 10-Q · filed 2021-11-12 | $246.61M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$56.00K 10-Q · filed 2021-08-13 | $88.32M derived: sum of 3 quarters · filed 2021-08-13 | $88.81M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $9.00K 10-Q · filed 2021-05-14 | $88.39M derived: sum of 2 quarters · filed 2021-05-14 | $88.87M derived: sum of 3 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $88.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $88.86M derived: sum of 2 quarters · filed 2021-03-25 | $107.70M 10-K · filed 2021-03-25 | |||
| 2019-09-30 | $488.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $19.32M 10-Q · filed 2020-11-13 | ||||
| 2019-06-30 | $18.84M 10-Q · filed 2020-08-13 | |||||
| 2018-12-31 | $23.77M 10-K · filed 2020-03-18 | |||||
| 2018-09-30 | $14.77M 10-Q · filed 2019-12-18 |